|
Real-time
Euronext Paris
00:04:42 04/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 80.90 EUR | +0.33% |
|
+7.68% | -2.18% |
| 11-03 | New board chairs for Adsure, EDX, Mpac and Pulsar | AN |
| 11-03 | Sanofi : RBC is Neutral | ZD |
Company Valuation: Sanofi
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,194 | 112,665 | 112,549 | 116,968 | 100,655 | 96,600 | - | - |
| Change | - | 1.32% | -0.1% | 3.93% | -13.95% | -4.03% | - | - |
| Enterprise Value (EV) 1 | 121,177 | 119,102 | 120,342 | 125,740 | 111,663 | 108,304 | 104,552 | 101,457 |
| Change | - | -1.71% | 1.04% | 4.49% | -11.2% | -3.01% | -3.46% | -2.96% |
| P/E | 17.8x | 16.7x | 20.8x | 20.4x | 12.9x | 13.4x | 11.1x | 9.5x |
| PBR | 1.62x | 1.5x | 1.52x | 1.51x | 1.41x | 1.29x | 1.22x | 1.15x |
| PEG | - | 2.07x | -1.1x | 3.14x | 0.3x | -2.22x | 0.5x | 0.6x |
| Capitalization / Revenue | 2.94x | 2.62x | 2.61x | 2.85x | 2.31x | 1.99x | 1.89x | 1.79x |
| EV / Revenue | 3.21x | 2.77x | 2.79x | 3.06x | 2.56x | 2.23x | 2.05x | 1.88x |
| EV / EBITDA | 9.95x | 8.14x | 8.44x | 9.76x | 8.22x | 6.97x | 6.57x | 5.89x |
| EV / EBIT | 11.3x | 9.13x | 9.5x | 11.1x | 9.19x | 7.92x | 7.34x | 6.6x |
| EV / FCF | 15x | 14x | 14.2x | 21.1x | 13.8x | 14x | 11.3x | 9.84x |
| FCF Yield | 6.68% | 7.12% | 7.04% | 4.74% | 7.24% | 7.12% | 8.86% | 10.2% |
| Dividend per Share 2 | 3.33 | 3.56 | 3.76 | 3.92 | 4.12 | 4.255 | 4.51 | 4.776 |
| Rate of return | 3.76% | 3.96% | 4.19% | 4.18% | 4.98% | 5.28% | 5.59% | 5.92% |
| EPS 2 | 4.97 | 5.37 | 4.31 | 4.59 | 6.4 | 6.013 | 7.29 | 8.483 |
| Distribution rate | 67% | 66.3% | 87.2% | 85.4% | 64.4% | 70.8% | 61.9% | 56.3% |
| Net sales 1 | 37,761 | 42,997 | 43,070 | 41,081 | 43,626 | 48,490 | 51,010 | 53,939 |
| EBITDA 1 | 12,183 | 14,627 | 14,259 | 12,889 | 13,583 | 15,537 | 15,921 | 17,230 |
| EBIT 1 | 10,714 | 13,040 | 12,670 | 11,343 | 12,149 | 13,683 | 14,235 | 15,363 |
| Net income 1 | 6,223 | 6,720 | 5,400 | 5,744 | 7,813 | 7,690 | 8,933 | 10,377 |
| Net Debt 1 | 9,983 | 6,437 | 7,793 | 8,772 | 11,008 | 11,704 | 7,952 | 4,856 |
| Reference price 2 | 88.58 | 89.84 | 89.76 | 93.74 | 82.72 | 80.63 | 80.63 | 80.63 |
| Nbr of stocks (in thousands) | 1,255,293 | 1,254,060 | 1,253,891 | 1,247,793 | 1,216,810 | 1,198,069 | - | - |
| Announcement Date | 4/2/22 | 3/2/23 | 1/2/24 | 30/1/25 | 29/1/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 13.41x | 2.23x | 7.02x | 5.28% | 108B | ||
| 41.24x | 13.98x | 31x | 0.48% | 1,257B | ||
| 39.6x | 6.65x | 18.71x | 1.97% | 651B | ||
| 36.2x | 8.44x | 17.42x | 2.4% | 510B | ||
| 21.41x | 5.2x | 12.95x | 2.52% | 388B | ||
| 98.19x | 6.02x | 25.62x | 2.29% | 366B | ||
| 22.92x | 5.89x | 14.21x | 2.72% | 303B | ||
| 24.43x | 4.89x | 13.76x | 1.79% | 288B | ||
| 29.52x | 7.52x | 13.46x | 2.17% | 252B | ||
| -40.78x | 7.43x | 46.67x | 1.94% | 211B | ||
| Average | 28.62x | 6.83x | 20.08x | 2.36% | 433.49B | |
| Weighted average by Cap. | 35.66x | 8.61x | 22.31x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SAN Stock
- Valuation Sanofi
Select your edition
All financial news and data tailored to specific country editions
















